HOMEVULNERABILITIESCVE-2025-46606
MEDIUM

CVE-2025-46606

CWE-307Published: April 17, 2026· Updated: Apr 17, 2026

6.2
CVSS v3.1
EPSS:0.02%probability of exploitation in 30 daysPercentile:5.6th

Official Description

Dell PowerProtect Data Domain with Data Domain Operating System (DD OS) of Feature Release versions 8.4 through 8.5 contain an improper restriction of excessive authentication attempts vulnerability. A high privileged attacker with remote access could potentially exploit this vulnerability, leading to unauthorized access.

NVD Source

Technical Analysis

CVE-2025-46606 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires high privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), with a CVSS base score of 6.2.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.High
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityLow
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:U/C:H/I:H/A:L

Affected Vendors & Products

Mentioned vendors (from description):
Dell
CPE data not yet available in NVD for this CVE.

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

All References (1)

Quick Facts

CVE IDCVE-2025-46606
CVSS Score6.2 / 10
SeverityMEDIUM
WeaknessCWE-307
CISA KEVNo
EPSS (30d)0.02%
PublishedApr 17, 2026

Related CVEs (CWE-307)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2025-46606 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.